GlobalData on MSN9h
Gilead’s lenacapavir moves closer to FDA approval for HIV PrEP useThe US Food and Drug Administration (FDA) has accepted Gilead’s new drug application (NDA) for lenacapavir and set a prescription drug user fee act (PDUFA) target action date of ...
By paralyzing frontline response efforts led by community groups, the US decision to freeze funding is weakening health systems across the Global South. The freeze not only jeopardizes precious gains ...
The FDA has accepted Gilead Sciences’ new drug application for lenacapavir as a long-lasting injectable to prevent HIV ...
The U.N.'s Angeli Achrekar reports that many clinics have closed, despite exemptions in the policy. She fears mortality will ...
Researchers at The Wistar Institute's HIV Cure and Viral Diseases Center have successfully identified a new approach using ...
Hosted on MSN14h
FEATURED: Condoms remain top choice for preventing HIV — AIDS Healthcare FoundationCondoms are among the most effective methods for preventing the sexual transmission of HIV, according to the AIDS Healthcare Foundation (AHF) in Rwanda. AHF Rwanda offers comprehensive services, ...
Offering state HIV patients who qualify a six-month supply of antiretroviral pills at a time is one of the goals in the ...
Lisburn & Castlereagh City Council has joined a global United Nations (UN) drive to help end new diagnoses of HIV: Fast Track ...
A trial of an earlier, separate vaccine candidate, which was about to be tested on humans in South Africa as well as Kenya ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback